It is known that studies of drug treatments It is known that studies of drug treatments are more likely to report favourable outare more likely to report favourable outcomes when they are funded by drug comcomes when they are funded by drug companies panies ( Lexchin , 2003; Lexchin et et al al, 2003) . There is also concern over the , 2003) . There is also concern over the conflict of interest created by authors' perconflict of interest created by authors' personal financial links to companies (Bodensonal financial links to companies (Bodenheimer, 2000; heimer, 2000; Komsaroff & Kerridge, Komsaroff & Kerridge, 2002) . Most studies of these influences are 2002). Most studies of these influences are based upon randomised controlled trials based upon randomised controlled trials in internal medicine. The study reported in internal medicine. The study reported here concerns a broad range of drug trials here concerns a broad range of drug trials in psychiatry. We explore the difference in psychiatry. We explore the difference between having an author who is an 'embetween having an author who is an 'employee' of a drug company (defined here ployee' of a drug company (defined here as holding a consultancy, being an employas holding a consultancy, being an employee or being a shareholder) and receiving ee or being a shareholder) and receiving financial support from a drug company, financial support from a drug company, and how these influence study outcome in and how these influence study outcome in comparison with independent studies. comparison with independent studies.
METHOD METHOD
The The British Journal of Psychiatry British Journal of Psychiatry, , AmeriAmerican Journal of Psychiatry can Journal of Psychiatry and and Archives of Archives of General Psychiatry General Psychiatry were selected as being were selected as being widely read journals. They were surveyed widely read journals. They were surveyed for original data-based papers concerning for original data-based papers concerning psychiatric drug treatment, published bepsychiatric drug treatment, published between January 2000 and December 2004 tween January 2000 and December 2004 inclusive. All methodologies were included inclusive. All methodologies were included (e.g. randomised controlled trials (RCTs), (e.g. randomised controlled trials (RCTs), studies of drug levels in breast milk). studies of drug levels in breast milk). Journals were searched manually and Journals were searched manually and information was collected from full-text information was collected from full-text versions. versions.
Outcomes were rated by T.T. He was Outcomes were rated by T.T. He was aware of funding, as this was apparent in aware of funding, as this was apparent in the papers. Studies were classified as rethe papers. Studies were classified as reporting positive findings porting positive findings if they clearly staif they clearly stated that use of the index drug led to a better ted that use of the index drug led to a better clinical outcome or was better tolerated clinical outcome or was better tolerated than another treatment. Studies were classithan another treatment. Studies were classified as reporting negative findings fied as reporting negative findings if they if they clearly stated that use of a comparison clearly stated that use of a comparison treatment led to a better outcome or was treatment led to a better outcome or was better tolerated than the index drug or that better tolerated than the index drug or that there was no difference in clinical outcome there was no difference in clinical outcome or tolerability. Where the conclusions in the or tolerability. Where the conclusions in the full text and abstract were equivocal, T.T. full text and abstract were equivocal, T.T. made a judgement as to whether the balance made a judgement as to whether the balance of findings was positive or negative. of findings was positive or negative.
Papers were included from all psychiPapers were included from all psychiatric sub-specialties. Outcome studies were atric sub-specialties. Outcome studies were included that compared an index drug with included that compared an index drug with placebo, another drug or a psychological placebo, another drug or a psychological therapy. Studies were excluded if they therapy. Studies were excluded if they concerned an index drug that was long concerned an index drug that was long established (e.g. tricyclic antidepressants, established (e.g. tricyclic antidepressants, lithium, older antipsychotics) unless it was lithium, older antipsychotics) unless it was being used for a novel indication (e.g. being used for a novel indication (e.g. testosterone for resistant depression). Short testosterone for resistant depression). Short reports, letters to the editor, editorials, reports, letters to the editor, editorials, review articles and meta-analyses were review articles and meta-analyses were excluded. excluded.
The authors' relationship with the drug The authors' relationship with the drug company was determined from declared afcompany was determined from declared affiliations and conflicts of interest, or from filiations and conflicts of interest, or from acknowledgements. Studies were classified acknowledgements. Studies were classified as industry-funded if the study was wholly as industry-funded if the study was wholly or partly funded by a drug company, inor partly funded by a drug company, including funding in kind (provision of drugs cluding funding in kind (provision of drugs and placebos, or an author who was an and placebos, or an author who was an employee). Authors were regarded as employee). Authors were regarded as employees if they worked full time for the employees if they worked full time for the company, or declared consultancy positions company, or declared consultancy positions or shareholdings. Studies were regarded as or shareholdings. Studies were regarded as independently funded if sufficient informaindependently funded if sufficient information was provided to exclude any of these tion was provided to exclude any of these relationships. relationships.
RESULTS RESULTS
Of the 198 studies that met the inclusion Of the 198 studies that met the inclusion criteria, 8 (4%) lacked sufficient inforcriteria, 8 (4%) lacked sufficient information on funding and were excluded. mation on funding and were excluded. The remaining studies fell into three The remaining studies fell into three groups: groups:
(a) (a) studies funded independently of the studies funded independently of the drug industry ('independent'); drug industry ('independent');
(b) (b) studies with one or more authors studies with one or more authors employed by a drug company ('industryemployed by a drug company ('industryauthored'); authored');
(c) (c) studies funded by industry but without an studies funded by industry but without an employee author ('industry-sponsored'). employee author ('industry-sponsored').
Of these 190 studies, 33 (17%) were Of these 190 studies, 33 (17%) were published in the published in the British Journal of PsyBritish Journal of Psychiatry chiatry, 98 (52%) in the , 98 (52%) in the American Journal American Journal of Psychiatry of Psychiatry and 59 (31%) in the and 59 (31%) in the Archives Archives of General Psychiatry of General Psychiatry. Most studies (157) . Most studies (157) concerned adults; the remainder concerned concerned adults; the remainder concerned elderly people, children, or mothers and elderly people, children, or mothers and babies. Of the 132 studies that were ranbabies. Of the 132 studies that were randomised controlled trials, 112 (85%) were domised controlled trials, 112 (85%) were industry-funded. In 75% of studies the industry-funded. In 75% of studies the index drug was an antipsychotic or an antiindex drug was an antipsychotic or an antidepressant (Table 1) . depressant (Table 1) .
There was a significant difference There was a significant difference between journals in reporting of negative between journals in reporting of negative results, the results, the British Journal of Psychiatry British Journal of Psychiatry being more likely to report negative findbeing more likely to report negative findings than the other two ( ings than the other two (w w 
Financial relationship with the drug Financial relationship with the drug industry industry
Forty-four studies (23%) were indepenForty-four studies (23%) were independent. Of the 146 that were industry-funded, dent. Of the 146 that were industry-funded, 58 (40%) also received funding from a 58 (40%) also received funding from a non-industry source. Six pharmaceutical non-industry source. Six pharmaceutical companies funded nearly half of all the companies funded nearly half of all the studies surveyed. There were 76 industrystudies surveyed. There were 76 industryauthored studies (40%); of these, 64 authored studies (40%); of these, 64 (84%) had authors who were employees (84%) had authors who were employees or shareholders. Seventy studies (37%) or shareholders. Seventy studies (37%) were industry-sponsored. were industry-sponsored. 
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DISCUSSION DISCUSSION
The involvement of a drug company emThe involvement of a drug company employee seems to exert a powerful effect on ployee seems to exert a powerful effect on study outcome, whereas merely accepting study outcome, whereas merely accepting industry sponsorship appears to have little industry sponsorship appears to have little or no effect. This finding is both novel or no effect. This finding is both novel and counter-intuitive. One might expect and counter-intuitive. One might expect that the difference between the two forms that the difference between the two forms of industry funding would be subtle. In of industry funding would be subtle. In fact, the difference is highly statistically fact, the difference is highly statistically significant, in contrast to the lack of significant, in contrast to the lack of difference between studies with financial difference between studies with financial sponsorship only and fully independent sponsorship only and fully independent studies. studies.
There are some factors that might have There are some factors that might have confounded our findings. There were more confounded our findings. There were more RCTs among the industry-funded studies. RCTs among the industry-funded studies. Unlike other investigators, we included all Unlike other investigators, we included all methodologies because the number of indemethodologies because the number of independent RCTs in psychiatry is small. It pendent RCTs in psychiatry is small. It might be that RCTs are intrinsically more might be that RCTs are intrinsically more likely to produce positive findings. Equally, likely to produce positive findings. Equally, they might be particularly vulnerable to they might be particularly vulnerable to being abandoned when preliminary findbeing abandoned when preliminary findings are not promising (Henry ings are not promising (Henry et al et al, , 2005 ). We did not assess the scientific 2005). We did not assess the scientific quality of different studies. It is possible quality of different studies. It is possible that independent studies tend to be stathat independent studies tend to be statistically underpowered and that this tistically underpowered and that this leads to overreporting of negative findleads to overreporting of negative findings (Djulbergovic ings (Djulbergovic et al et al, 2000; Procyshyn , 2000; Procyshyn et al et al, 2004) .
, 2004).
Our findings are unlikely to be solely Our findings are unlikely to be solely due to these factors. All previous studies due to these factors. All previous studies comparing industry-funded RCTs with comparing industry-funded RCTs with independent ones have shown that the independent ones have shown that the former are more likely to report positive former are more likely to report positive findings. If industry-funded studies are less findings. If industry-funded studies are less likely to be underpowered or methodologilikely to be underpowered or methodologically flawed, then one would expect that cally flawed, then one would expect that the reporting of negative findings would the reporting of negative findings would be similar in the industry-authored and inbe similar in the industry-authored and industry-sponsored groups, whereas actually dustry-sponsored groups, whereas actually the sponsored and independent studies the sponsored and independent studies were similar. We seem to have found an were similar. We seem to have found an 'all or nothing' effect related to the involve-'all or nothing' effect related to the involvement of a drug company employee. ment of a drug company employee.
In conclusion, we have confirmed preIn conclusion, we have confirmed previous findings that industry-funded studies vious findings that industry-funded studies are less likely to report negative findings. are less likely to report negative findings. Our novel finding is that this effect appears Our novel finding is that this effect appears to be largely or exclusively due to the preto be largely or exclusively due to the presence of a company employee among the sence of a company employee among the authorship. This finding requires replicaauthorship. This finding requires replication with attention to differences in studies' tion with attention to differences in studies' methodological rigour and statistical methodological rigour and statistical power, in order to exclude these as power, in order to exclude these as confounding variables. confounding variables. 
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